SGRKX
Price
$41.83
Change
-$0.03 (-0.07%)
Updated
Dec 3 closing price
Net Assets
3.47B
VIGRX
Price
$253.05
Change
+$0.01 (+0.00%)
Updated
Dec 3 closing price
Net Assets
357.2B
Interact to see
Advertisement

SGRKX vs VIGRX

Header iconSGRKX vs VIGRX Comparison
Open Charts SGRKX vs VIGRXBanner chart's image
Allspring Growth Admin
Price$41.83
Change-$0.03 (-0.07%)
VolumeN/A
Net Assets3.47B
Vanguard Growth Index Investor
Price$253.05
Change+$0.01 (+0.00%)
VolumeN/A
Net Assets357.2B
SGRKX vs VIGRX Comparison Chart in %
View a ticker or compare two or three
VS
SGRKX vs. VIGRX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SGRKX is a Buy and VIGRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 357B vs. SGRKX (3.47B). VIGRX pays higher dividends than SGRKX: VIGRX (0.30) vs SGRKX (0.00). SGRKX was incepted earlier than VIGRX: SGRKX (23 years) vs VIGRX (33 years). SGRKX (1.11) is less costly to investors than VIGRX (0.17). SGRKX is a more actively managed with annual turnover of: 73.00 vs. VIGRX (11.00). VIGRX has a lower initial minimum investment than SGRKX: VIGRX (3000) vs SGRKX (1000000). VIGRX annual gain was more profitable for investors over the last year : 18.49 vs. SGRKX (-10.64). VIGRX return over 5 years is better than : 99.11 vs. SGRKX (-24.91).
SGRKXVIGRXSGRKX / VIGRX
Total Expense Ratio0.960.17565%
Annual Report Gross Expense Ratio1.110.17653%
Fund Existence23 years33 years-
Gain YTD17.13819.76487%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets3.47B357B1%
Annual Yield % from dividends0.000.30-
Returns for 1 year-10.6418.49-58%
Returns for 3 years31.67110.8229%
Returns for 5 years-24.9199.11-25%
Returns for 10 years-17.87349.13-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STOK30.961.15
+3.86%
Stoke Therapeutics
NEPH5.400.09
+1.69%
Nephros
TACO10.15N/A
N/A
Berto Acquisition Corp
HVIIU10.60N/A
N/A
Hennessy Capital Investmnt Corp VII
AHR50.31-0.13
-0.26%
American Healthcare REIT